However, recent reports have suggested that NSE demonstrates low sensitivity in the early detection of SCLC, and positive expressions quickly occur in NSCLC and hemolytic specimens, which limits its clinical application [11]. The gene discussed is ENO2; the disease is non-small cell lung carcinoma.